Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis

PURPOSE: Programmed death-1 (PD-1) and its ligand (PD-L1) inhibitors have been reported in several clinical trials for gastric cancer and gastroesophageal junction cancer (GC/GEJC). We presently carried out a meta analysis to evaluate the potency of PD-1/PD-L1 inhibitors in advanced GC/GEJC individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Gengwei, Liu, Wenjie, Chen, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921519/
https://www.ncbi.nlm.nih.gov/pubmed/36765356
http://dx.doi.org/10.1186/s12885-023-10605-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921519/
https://www.ncbi.nlm.nih.gov/pubmed/36765356
http://dx.doi.org/10.1186/s12885-023-10605-y

Ejemplares similares